Toxicity Linked to Longer Survival in Patients With NSCLC Toxicity Linked to Longer Survival in Patients With NSCLC
A new cohort study shows that some immune-related adverse events are linked to longer survival in patients with NSCLC treated with immunotherapy.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
More News: Cancer & Oncology | Health | Hematology | Immunotherapy | Non-Small Cell Lung Cancer | Study | Toxicology